Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook [Yahoo! Finance]
Akoya BioSciences, Inc. (AKYA)
Company Research
Source: Yahoo! Finance
FY 2024 Revenue Guidance : The company projects revenue between $114.0-118.0 million. Operating Cash Flow : Akoya aims for operating cash flow breakeven by the end of 2024. Net Loss : Q4 net loss was $10.8 million, with a full-year net loss of $63.3 million. Balance Sheet : Cash and cash equivalents stood at $83.1 million as of December 31, 2023. Warning! GuruFocus has detected 3 Warning Signs with AKYA. On March 4, 2024, Akoya Biosciences Inc ( NASDAQ:AKYA ) released its 8-K filing , announcing a record fourth-quarter revenue of $26.5 million and a full-year revenue of $96.6 million for 2023. The life sciences technology company, known for its spatial biology solutions, has provided a positive financial outlook for 2024, with revenue guidance set between $114.0 and $118.0 million and an expectation to reach operating cash flow breakeven by year-end. Akoya Biosciences Inc, with its strong presence in North America, APAC, and EMEA, has made significant strides in the Medic
Show less
Read more
Impact Snapshot
Event Time:
AKYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKYA alerts
High impacting Akoya BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
AKYA
News
- Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024GlobeNewswire
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleGlobeNewswire
- Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences Names BostonGene as a Qualified CRO Service ProviderBusiness Wire
AKYA
Earnings
- 3/4/24 - Beat
AKYA
Sec Filings
- 4/23/24 - Form ARS
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEF
- AKYA's page on the SEC website